A Multicenter, Randomized, Double-Blind, Phase 2 Study to Evaluate the Effect of Febuxostat Versus Placebo on Renal Function in Gout Subjects With Hyperuricemia and Moderate to Severe Renal Impairment.
Phase of Trial: Phase II
Latest Information Update: 19 Feb 2016
At a glance
- Drugs Febuxostat (Primary)
- Indications Hyperuricaemia
- Focus Therapeutic Use
- 19 Feb 2016 Results of exploratory study published in the Arthritis and Rheumatology
- 25 Jun 2012 Actual end date Jun 2012 added as reported by ClinicalTrials.gov.
- 25 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.